Wasatch Advisors LP lessened its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 0.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,038,489 shares of the company's stock after selling 4,751 shares during the period. Wasatch Advisors LP owned about 5.73% of Addus HomeCare worth $130,175,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Smartleaf Asset Management LLC raised its stake in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares during the period. Meeder Asset Management Inc. acquired a new position in shares of Addus HomeCare in the 4th quarter valued at about $77,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Addus HomeCare in the fourth quarter worth about $86,000. Finally, KBC Group NV boosted its stake in shares of Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock valued at $102,000 after buying an additional 268 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.
Addus HomeCare Stock Performance
Shares of ADUS traded down $2.38 during mid-day trading on Monday, reaching $98.87. The company had a trading volume of 56,055 shares, compared to its average volume of 164,375. The firm has a 50-day moving average price of $99.45 and a 200 day moving average price of $116.98. Addus HomeCare Co. has a 52 week low of $87.88 and a 52 week high of $136.72. The company has a market capitalization of $1.80 billion, a price-to-earnings ratio of 22.62, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. As a group, research analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the company. Oppenheimer boosted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. JMP Securities reissued a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Thursday, April 10th. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Macquarie reaffirmed an "outperform" rating and set a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, Stephens reiterated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $132.78.
Check Out Our Latest Analysis on ADUS
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
